Showing results (41-50 of 350) with videos related to
Sort By:
Pageof 35
Current Oncology Reports|May 4, 2010
Oral cancer chemotherapy: the critical interplay between patient education and patient safetyThorvardur R Halfdanarson, Aminah JatoiJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 1, 2007
Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online?Mohammad Anas Alsawaf, Aminah JatoiJournal of Gastrointestinal Cancer|January 8, 2009
An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancerTow S Tan, Aminah JatoiActa Oncologica (Stockholm, Sweden)|November 27, 2010
Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patientsJudi Anne B Ramiscal, Aminah JatoiThe Oncologist|January 20, 2019
Numbers Have Life: A Commentary on "Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit"Jennifer G Le-Rademacher, Aminah JatoiThe American Journal of Hospice & Palliative Care|September 29, 2022
Healthcare Providers' Experiences with Hiccups in Patients with Cancer: Report of a United States National SurveyJana Wieland, Nichole Martin, Aminah JatoiJournal of Palliative Medicine|March 7, 2019
Poly (ADP-Ribose) Polymerase Inhibition for Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Placebo-Controlled TrialsRyan Balko, Rachel Hurley, Aminah JatoiMedical Oncology (Northwood, London, England)|March 15, 2011
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumabTimothy Poterucha, Brian Burnette, Aminah JatoiThe Journal of Supportive Oncology|August 27, 2004
Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on managementAnne Kanard, Stephen Frytak, Aminah JatoiCurrent Oncology Reports|May 1, 2012
Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilanceJudi Anne B Ramiscal, Aminah JatoiPageof 35